FTC sues main pharmacy benefit supervisors above insulin selling prices The agency introduced action in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the list price of existence-saving insulin drugs. Where are all the nurses? Hospitals, advocates disagree on crisis Hospitals https://kethek.com/